A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France

BACKGROUND: We have previously shown that a panel of kallikrein markers - total prostate-specific antigen (PSA), free PSA, intact PSA and human kallikrein-related peptidase 2 (hK2) - can predict the outcome of prostate biopsy in men with elevated PSA. Here we investigate the properties of our panel...

Descripción completa

Detalles Bibliográficos
Autores principales: Benchikh, Amine, Savage, Caroline, Cronin, Angel, Salama, Gilles, Villers, Arnauld, Lilja, Hans, Vickers, Andrew
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996396/
https://www.ncbi.nlm.nih.gov/pubmed/21092177
http://dx.doi.org/10.1186/1471-2407-10-635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996396/
https://www.ncbi.nlm.nih.gov/pubmed/21092177
http://dx.doi.org/10.1186/1471-2407-10-635

Ejemplares similares